Last reviewed · How we verify

spinal administration of bupivacaine

Reinier de Graaf Groep · Phase 3 active Small molecule

spinal administration of bupivacaine is a Small molecule drug developed by Reinier de Graaf Groep. It is currently in Phase 3 development.

At a glance

Generic namespinal administration of bupivacaine
SponsorReinier de Graaf Groep
ModalitySmall molecule
PhasePhase 3

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about spinal administration of bupivacaine

What is spinal administration of bupivacaine?

spinal administration of bupivacaine is a Small molecule drug developed by Reinier de Graaf Groep.

Who makes spinal administration of bupivacaine?

spinal administration of bupivacaine is developed by Reinier de Graaf Groep (see full Reinier de Graaf Groep pipeline at /company/reinier-de-graaf-groep).

What development phase is spinal administration of bupivacaine in?

spinal administration of bupivacaine is in Phase 3.

Related